Browsing Tag
Dexamethasone
11 posts
Is the worst behind for Natural Capsules (NSE: NATCAPSUQ) after API delays and US tariff headwinds?
Natural Capsules reports Q2FY26 loss amid US tariff pressure and API delays. Find out if its PLI benefits and expansion plans can turn the tide.
GSK’s DREAMM-7 trial shows promising results for Blenrep in multiple myeloma
GSK plc has unveiled positive outcomes from the DREAMM-7 head-to-head phase III trial, evaluating Blenrep (belantamab mafodotin) as…
Legend Biotech announces submission of CARVYKTI application to EMA for multiple myeloma
Legend Biotech has announced the submission of a Type II variation application to the European Medicines Agency (EMA)…
Natco Pharma launches PrNAT-LENALIDOMIDE Capsules in Canada
Natco Pharma Limited has announced the Canadian launch of PrNAT-LENALIDOMIDE Capsules, a generic version of Celgene Corporation’s cancer…
Janssen Pharmaceutical’s DARZALEX FASPRO gains FDA approval for AL amyloidosis treatment
Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has secured FDA approval for DARZALEX FASPRO (daratumumab and hyaluronidase-fihj),…
Takeda’s NINLARO fails to meet PFS primary endpoint in TOURMALINE-MM2 trial
Takeda Pharmaceutical said that the Phase 3 TOURMALINE-MM2 trial in newly diagnosed multiple myeloma patients for NINLARO (ixazomib)…
Janssen, Amgen secure FDA approval for DKd regiment in multiple myeloma
DKd regiment FDA approval for multiple myeloma : Janssen Pharmaceutical Companies of Johnson & Johnson and Amgen have…
Dexamethasone improves survival of COVID-19 patients in RECOVERY trial
The University of Oxford said that steroid dexamethasone has succeeded in reducing death in the ongoing RECOVERY trial…
RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford
RECOVERY coronavirus trial : University of Oxford researchers in the UK have initiated a coronavirus clinical trial called…
CANDOR clinical trial results : Amgen’s Kyprolis extends PFS in multiple myeloma patients
CANDOR clinical trial results : Amgen said that a phase 3 study assessing Kyprolis (carfilzomib) in combination with…